Wavestone SA header image

Wavestone SA

WAVE

Equity

ISIN FR0013357621 / Valor 43511250

Euronext - Euronext Paris (2025-04-04)
EUR 44.20-3.70%

Wavestone SA
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Wavestone SA is a global consulting firm that specializes in advising technology leaders on various aspects of their business, including sustainability, cybersecurity, and the implementation of generative AI. The company conducts surveys and research to provide insights to CIOs, CTOs, CDOs, and CISOs on how to navigate the challenges and opportunities presented by emerging technologies. Wavestone SA aims to help its clients stay ahead of the curve in a rapidly evolving digital landscape.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (14.01.2025):

Revenue Growth

In the first half of the 2024/25 fiscal year, Wavestone SA reported a significant increase in revenue, reaching €457.8 million. This marks a 65% growth compared to the same period in the previous year, H1 2023/24, where revenue was €276.7 million. The growth includes contributions from the acquisitions of Q_PERIOR and Aspirant Consulting.

Operating Profit and Margin

Wavestone SA's recurring operating profit for H1 2024/25 increased by 26% to €46.4 million, up from €36.8 million in H1 2023/24. However, the recurring operating margin decreased to 10.1% from 13.3% in the previous year, impacted by integration costs and seasonal effects.

Net Income and Margin

The net income for Wavestone SA in H1 2024/25 rose by 19% to €27.3 million, compared to €23.0 million in the same period last year. This resulted in a net margin of 6.0%, down from 8.3% in H1 2023/24, influenced by increased financial debt costs and tax expenses.

Financial Structure

As of September 30, 2024, Wavestone SA's equity group share was €578.4 million, up from €569.5 million at the end of March 2024. The net cash position turned negative at €(38.5) million, compared to a positive €19.3 million at the end of March 2024, due to increased financial liabilities and recent acquisitions.

Cash Flow and Investments

Wavestone SA's self-financing capacity increased by 38% to €54.3 million in H1 2024/25. Despite this, operating cash flow was €2.5 million, down from €9.3 million in the previous year, due to changes in working capital and higher tax payments. Investment operations consumed €37.8 million, primarily for Q_PERIOR's earn-out payment.

Summarized from source with an LLMView Source

Key figures

-20.5%1Y
-4.43%3Y
171%5Y

Performance

33.5%1Y
33.0%3Y
35.0%5Y

Volatility

Market cap

1091 M

Market cap (USD)

Daily traded volume (Shares)

13,663

Daily traded volume (Shares)

1 day high/low

42.2 / 41.25

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Jabil Inc
Jabil Inc Jabil Inc Valor: 71588
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.35%USD 116.88
Unity Software Inc
Unity Software Inc Unity Software Inc Valor: 56795613
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.98%USD 16.92
Xerox Holdings Corporation
Xerox Holdings Corporation Xerox Holdings Corporation Valor: 49153526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.31%USD 4.00
HashiCorp Inc
HashiCorp Inc HashiCorp Inc Valor: 114723641
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 34.78
Sage Therapeutics Inc
Sage Therapeutics Inc Sage Therapeutics Inc Valor: 24747713
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.92%USD 6.86
LEGRAND SA
LEGRAND SA LEGRAND SA Valor: 2501522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.04%EUR 89.38
Amdocs Ltd
Amdocs Ltd Amdocs Ltd Valor: 922906
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.24%USD 83.70
F5 Inc
F5 Inc F5 Inc Valor: 812258
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.67%USD 239.25
Natera Inc
Natera Inc Natera Inc Valor: 28447012
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.49%USD 133.87
Magnite Inc
Magnite Inc Magnite Inc Valor: 55798557
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.39%USD 9.08